Don’t miss the latest developments in business and finance.

Markets remain vigilant as Brexit referendum begins

The referendum will decide Britian's future in, or out, of the European Union.

Markets remain vigilant as the Brexit referendum begins
SI Reporter Mumbai
Last Updated : Jun 23 2016 | 11:58 AM IST
Markets continue to remain subdued as the Brexit referendum begins which will decide Britian’s future in, or out, of the European Union.

At 11:50 am, the S&P BSE Sensex was down 15 points at 26,751 and the Nifty50 was down 9 points at 8,195.

Meanwhile, rupee appreciated 15 paise to 67.33 against the US dollar in early trade today on increased selling of the American currency by bankers and exporters.

KEY STOCKS

NTPC falls 3% after the government decided to sell 2.06 crore shares in NTPC to eligible employees at a price of Rs115.90, a 5% discount to the price of Rs 122 at which the government sold 5% stake in the power generator in February.

Max Ventures and Industries hit upper circuit on Thursday for the second trading session after the listing on bourses on Wednesday.

More From This Section


Reliance Communications (RCom) was trading higher by 3% after the rating agency ICRA on Wednesday upgraded its outlook to stable from negative on the long term rating 'BBB+' of the company. 

KEC International has rallied 7% after the company in a release said that it has secured new orders worth of Rs 1,036 crore.

The coal ministry has issued a show-cause notice to Anil Ambani-led Reliance Power, seeking an explanation on the delay in development of coal blocks attached to the abandoned Tilaiya ultra mega power project (UMPP).  The stock lost over 1%.

The nation's biggest gas transporter GAIL has been awarded Rs 550 crore worth of contracts for laying part of 'Urga Ganga' gas pipeline from Phulpur in Uttar Pradesh to Haldia in West Bengal. The stock is trading with marginal losses.

Sun Pharma told the stock exchanges that its board will hold a meeting on June 23, 2016 for evaluating a proposal of Buy Back of Equity Shares of the Company. The stock jumped 2%.

Lupin has received final approval from the US health regulator to market generic Voriconazole tablets as well as oral suspension for treatment of fungal infections in the American market. The stock is up 1%.

Also Read

First Published: Jun 23 2016 | 11:53 AM IST

Next Story